Aspirin plus tirofiban inhibit the thrombosis induced by Russell’s viper venom

go back to reference Wüster W, Golay P, Warrell DA. Synopsis of recent development in venomous snake systematic. Toxicon. 1997;35(3):319–40.PubMedCrossRef Wüster W, Golay P, Warrell DA. Synopsis of recent development in venomous snake systematic. Toxicon. 1997;35(3):319–40.PubMedCrossRef

go back to reference Isbister GK. Snake bite Does’t Cause Disseminated Intravascular Coagulation: Coagulopathy and Thrombotic Microangiopathy in Snake Envenoming. Semin Thromb Hemost. 2010;36(4):444–51.PubMedCrossRef Isbister GK. Snake bite Does’t Cause Disseminated Intravascular Coagulation: Coagulopathy and Thrombotic Microangiopathy in Snake Envenoming. Semin Thromb Hemost. 2010;36(4):444–51.PubMedCrossRef

go back to reference Gawarammana I, Menchs S, Jeganathan K. Acute Ischemic Stroke due to bites by Daboiarusselli in Sri Lanka – First authenticated case series. Toxicon. 2009;54(4):421–8.PubMedCrossRef Gawarammana I, Menchs S, Jeganathan K. Acute Ischemic Stroke due to bites by Daboiarusselli in Sri Lanka – First authenticated case series. Toxicon. 2009;54(4):421–8.PubMedCrossRef

go back to reference Suntravat M, Yusuksawad M, Sereemaspun A, Pérez JC, Nuchprayoon I. Effect of purified Russell’s viper venom-factor X activator (RVV-X) on renal hemodynamics, renal functions, and coagulopathy in rats. Toxicon. 2011;58(3):230–8.PubMedPubMedCentralCrossRef Suntravat M, Yusuksawad M, Sereemaspun A, Pérez JC, Nuchprayoon I. Effect of purified Russell’s viper venom-factor X activator (RVV-X) on renal hemodynamics, renal functions, and coagulopathy in rats. Toxicon. 2011;58(3):230–8.PubMedPubMedCentralCrossRef

go back to reference Warrell DA. Snake venoms in science and clinical medicine. 1. Russell’s viper: biology, venom and treatment of bites. Trans R Soc Trop Med Hyg. 1989;83(6):732–40.PubMedCrossRef Warrell DA. Snake venoms in science and clinical medicine. 1. Russell’s viper: biology, venom and treatment of bites. Trans R Soc Trop Med Hyg. 1989;83(6):732–40.PubMedCrossRef

go back to reference Myint-Lwin, Warrell DA, Phillips RE, Tin-Nu-Swe, Tun-Pe, Maung-Maung-Lay. Bites by Russell’s viper (Viper russelli siamensis) in Burma: hemostatic, vascular and renal disturbance and response to treatment. Lancet. 1985; 2 (8467): 1259-64 Myint-Lwin, Warrell DA, Phillips RE, Tin-Nu-Swe, Tun-Pe, Maung-Maung-Lay. Bites by Russell’s viper (Viper russelli siamensis) in Burma: hemostatic, vascular and renal disturbance and response to treatment. Lancet. 1985; 2 (8467): 1259-64

go back to reference Phillips RE, Theakston RDG, Warrell DA, Galigedara Y, Abeysekera DT, Dissanayaka P, Huton RA, Aloysius DJ. Paralysis, rhabdomyolysis and hemolysis cause by bites of Russell’s viper (Viper russelli pulchella) in Sri Lanka: failure of Indian (Haffkine) antivenom. Q J Med. 1988;68(257):691–716.PubMed Phillips RE, Theakston RDG, Warrell DA, Galigedara Y, Abeysekera DT, Dissanayaka P, Huton RA, Aloysius DJ. Paralysis, rhabdomyolysis and hemolysis cause by bites of Russell’s viper (Viper russelli pulchella) in Sri Lanka: failure of Indian (Haffkine) antivenom. Q J Med. 1988;68(257):691–716.PubMed

go back to reference Than-Than, Francis N, Tin-Nu-Swe, Myint-Lwin, Tun-Pe, Soe-Soe, Maung-Maung O, Phillips RE, Warrell DA. Contribution of focal hemorrhage and microvascular fibrin deposition to fatal envenoming by Russell’s viper (Viper russelli siamensis) in Bruma. Acta Tropica.1989; 46 (1): 23-38 Than-Than, Francis N, Tin-Nu-Swe, Myint-Lwin, Tun-Pe, Soe-Soe, Maung-Maung O, Phillips RE, Warrell DA. Contribution of focal hemorrhage and microvascular fibrin deposition to fatal envenoming by Russell’s viper (Viper russelli siamensis) in Bruma. Acta Tropica.1989; 46 (1): 23-38

go back to reference Lee CY. Toxicological studies on the venom of Viper russelli formosensis. Part 1. Toxicity and pharmacological properties. J Formos Med Assoc. 1948;47:65–98. Lee CY. Toxicological studies on the venom of Viper russelli formosensis. Part 1. Toxicity and pharmacological properties. J Formos Med Assoc. 1948;47:65–98.

go back to reference Hung DZ. Taiwan's venomous snakebite: epidemiological, evolution and geographic differences. Trans R Soc Trop Med Hyg. 2004;98(2):96–101.PubMedCrossRef Hung DZ. Taiwan's venomous snakebite: epidemiological, evolution and geographic differences. Trans R Soc Trop Med Hyg. 2004;98(2):96–101.PubMedCrossRef

go back to reference Hung DZ, Wu ML, Deng JF, Lin-Shiau SY. Russell’s viper snakebites in Taiwan: differences from other Asian countries. Toxicon. 2002a; 40(9): 1291-8. Hung DZ, Wu ML, Deng JF, Lin-Shiau SY. Russell’s viper snakebites in Taiwan: differences from other Asian countries. Toxicon. 2002a; 40(9): 1291-8.

go back to reference Hung DZ, et al. Antivenom treatment and renal dysfunction in Russell's viper snakebite in Taiwan: a case series. Trans R Soc Trop Med Hyg. 2006;100(5):489–94.PubMedCrossRef Hung DZ, et al. Antivenom treatment and renal dysfunction in Russell's viper snakebite in Taiwan: a case series. Trans R Soc Trop Med Hyg. 2006;100(5):489–94.PubMedCrossRef

go back to reference Maduwage K, Isbister GK. Current Treatment for Venom-Induced Consumption Coagulopathy Resulting from Snakebite. PLoS Negl Trop Dis. 2014;8(10):e3220. doi:10.1371/journal.pntd.0003220.PubMedPubMedCentralCrossRef Maduwage K, Isbister GK. Current Treatment for Venom-Induced Consumption Coagulopathy Resulting from Snakebite. PLoS Negl Trop Dis. 2014;8(10):e3220. doi:10.​1371/​journal.​pntd.​0003220.PubMedPubMedCentralCrossRef

go back to reference Narang SK, Paleti S, Asad MA, Samina T. Acute ischemic infarct in the middle cerebral artery territory following a Russell’s viper bite. Neurol India. 2009;57(4):479–80.PubMedCrossRef Narang SK, Paleti S, Asad MA, Samina T. Acute ischemic infarct in the middle cerebral artery territory following a Russell’s viper bite. Neurol India. 2009;57(4):479–80.PubMedCrossRef

go back to reference Collet JP, Montalesco G, Lesty C, Weisel JW. A structural and dynamic investigation of the facilitating effect of glycoprotein IIb/IIIa inhibitors in dissolving platelet-rich clots. Circ Res. 2002;90(4):428–34.PubMedCrossRef Collet JP, Montalesco G, Lesty C, Weisel JW. A structural and dynamic investigation of the facilitating effect of glycoprotein IIb/IIIa inhibitors in dissolving platelet-rich clots. Circ Res. 2002;90(4):428–34.PubMedCrossRef

go back to reference Katzung BG. Basic and Clinical Pharmacology, 10th edition. International edition. New York, NY: McGraw-Hill; 2007a; pp. 576 Table 36-1. Katzung BG. Basic and Clinical Pharmacology, 10th edition. International edition. New York, NY: McGraw-Hill; 2007a; pp. 576 Table 36-1.

go back to reference Antithrombotic Trialists’s Collaboration. Collaborative meta-analysis of randomized trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ. 2002;324(7329):71–86.CrossRef Antithrombotic Trialists’s Collaboration. Collaborative meta-analysis of randomized trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ. 2002;324(7329):71–86.CrossRef

go back to reference Katzung BG. Basic and Clinical Pharmacology, 10th edition. International edition. New York, NY: McGraw-Hill; 2007b; pp. 300. Katzung BG. Basic and Clinical Pharmacology, 10th edition. International edition. New York, NY: McGraw-Hill; 2007b; pp. 300.

go back to reference Quinn M, Fitzgerald D. Platelet function. New Jersey U.S.A.: Human Press; 2005. p. 270.CrossRef Quinn M, Fitzgerald D. Platelet function. New Jersey U.S.A.: Human Press; 2005. p. 270.CrossRef

go back to reference Raychowdhury MK, Yukawa M, Collins LJ, et al. Alternative splicing produces a divergent cytoplasmic tail in the human endothelial thromboxane A2 receptor. J Biol Chem. 1994;269(30):19256–61.PubMed Raychowdhury MK, Yukawa M, Collins LJ, et al. Alternative splicing produces a divergent cytoplasmic tail in the human endothelial thromboxane A2 receptor. J Biol Chem. 1994;269(30):19256–61.PubMed

go back to reference Katzung BG. Basic and Clinical Pharmacology, 10th edition. International edition. New York, NY: McGraw-Hill; 2007c; pp. 295 and 299. Katzung BG. Basic and Clinical Pharmacology, 10th edition. International edition. New York, NY: McGraw-Hill; 2007c; pp. 295 and 299.

go back to reference Adams Jr HP, del Zoppo G, Alberts MJ, et al. Guidelines for the early management of adults with ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical cardiology Council, Cardiovascular Radiology and Interventional Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: the American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists. Stoke. 2007;38(5):1655–711. Adams Jr HP, del Zoppo G, Alberts MJ, et al. Guidelines for the early management of adults with ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical cardiology Council, Cardiovascular Radiology and Interventional Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: the American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists. Stoke. 2007;38(5):1655–711.

go back to reference Anderson JL, Adams CD, Antman EM, et al. ACC/AHA guidelines for the management of patients with unstable/angina/non-ST-Elevation myocardial infarction; a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Anginal/Non-ST-Elevation Myocardial infarction) developed in collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine. J Am Coll Cardiol. 2007;50(7):e1–e157.PubMedCrossRef Anderson JL, Adams CD, Antman EM, et al. ACC/AHA guidelines for the management of patients with unstable/angina/non-ST-Elevation myocardial infarction; a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Anginal/Non-ST-Elevation Myocardial infarction) developed in collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine. J Am Coll Cardiol. 2007;50(7):e1–e157.PubMedCrossRef

go back to reference Barritt DW, Jordon PM. Anticoagulant drugs in the treatment of pulmonary embolism: a controlled trial. Lancet. 1960;1(7138):1309–12.PubMedCrossRef Barritt DW, Jordon PM. Anticoagulant drugs in the treatment of pulmonary embolism: a controlled trial. Lancet. 1960;1(7138):1309–12.PubMedCrossRef

go back to reference Theroux P, Ouimet H, McCans J, Latour JG, Joly P, Levy G, et al. Aspirin, heparin, or both to treat acute unstable angina? N Engl J Med. 1988;319(17):1105–11.PubMedCrossRef Theroux P, Ouimet H, McCans J, Latour JG, Joly P, Levy G, et al. Aspirin, heparin, or both to treat acute unstable angina? N Engl J Med. 1988;319(17):1105–11.PubMedCrossRef

go back to reference Hull RD, Raskob GE, Hirsh J, Jay RM, Leclerc JR, Geerts WH, et al. Continuous intravenous heparin compared with intermittent subcutaneous heparin in the initial treatment of proximal-vein thrombosis. N Engl J Med. 1986;315(18):1109–14.PubMedCrossRef Hull RD, Raskob GE, Hirsh J, Jay RM, Leclerc JR, Geerts WH, et al. Continuous intravenous heparin compared with intermittent subcutaneous heparin in the initial treatment of proximal-vein thrombosis. N Engl J Med. 1986;315(18):1109–14.PubMedCrossRef

go back to reference Turpie AG, Robinson JG, Doyle DJ, Mulji AS, Mishkel GJ, Sealey BJ, et al. Comparison of high-dose with low-dose subcutaneous heparin to prevent left ventricular mural thrombosis in patients with acute transmural anterior myocardial infarction. N Engl J Med. 1989;320(6):352–7.PubMedCrossRef Turpie AG, Robinson JG, Doyle DJ, Mulji AS, Mishkel GJ, Sealey BJ, et al. Comparison of high-dose with low-dose subcutaneous heparin to prevent left ventricular mural thrombosis in patients with acute transmural anterior myocardial infarction. N Engl J Med. 1989;320(6):352–7.PubMedCrossRef

go back to reference Katzung BG. Basic and Clinical Pharmacology, 10th edition. International edition. New York, NY: McGraw-Hill; 2007d; pp. 546. Katzung BG. Basic and Clinical Pharmacology, 10th edition. International edition. New York, NY: McGraw-Hill; 2007d; pp. 546.

go back to reference Katzung BG. Basic and Clinical Pharmacology, 10th edition. International edition. New York, NY: McGraw-Hill; 2007e; pp. 543 Figure 34-1. Katzung BG. Basic and Clinical Pharmacology, 10th edition. International edition. New York, NY: McGraw-Hill; 2007e; pp. 543 Figure 34-1.

go back to reference Hirsh J. Heparin. N Engl J Med. 1991;324(22):1565–74.PubMedCrossRef Hirsh J. Heparin. N Engl J Med. 1991;324(22):1565–74.PubMedCrossRef

go back to reference Hechler B, Leon C, Vial C, Vigne P, Frelin C, Cazenave JP, Gachet C. The P2Y1 receptor is necessary for adenosine 5’-diphosphate-induced platelet aggregation. Blood. 1998;92(1):152–9.PubMed Hechler B, Leon C, Vial C, Vigne P, Frelin C, Cazenave JP, Gachet C. The P2Y1 receptor is necessary for adenosine 5’-diphosphate-induced platelet aggregation. Blood. 1998;92(1):152–9.PubMed

go back to reference Communi D, Janssens R, Suarez-Huerta N, Robaye B, Boeynaems JM. Advances in signaling by extracellular nucleotides, the role and transduction mechanisms of P2Y receptors. Cell Signal. 2000;12(6):351–60.PubMedCrossRef Communi D, Janssens R, Suarez-Huerta N, Robaye B, Boeynaems JM. Advances in signaling by extracellular nucleotides, the role and transduction mechanisms of P2Y receptors. Cell Signal. 2000;12(6):351–60.PubMedCrossRef

go back to reference Cattaneo M, Savage B, Ruggeri Z. Effects of pharmacological inhibition of the P2Y1 and P2Y12 ADP receptors on shear-induced platelet aggregation and platelet thrombus formation on a collagen-coated surface under flow condition. Blood. 2001;98:239a. Cattaneo M, Savage B, Ruggeri Z. Effects of pharmacological inhibition of the P2Y1 and P2Y12 ADP receptors on shear-induced platelet aggregation and platelet thrombus formation on a collagen-coated surface under flow condition. Blood. 2001;98:239a.

go back to reference Turner NA, Moake JL, McIntire LV. Blockade of adenosine diphosphate receptors P2Y12 and P2Y1 is required to inhibit platelet aggregation in whole blood under flow. Blood. 2001;98(12):3340–5.PubMedCrossRef Turner NA, Moake JL, McIntire LV. Blockade of adenosine diphosphate receptors P2Y12 and P2Y1 is required to inhibit platelet aggregation in whole blood under flow. Blood. 2001;98(12):3340–5.PubMedCrossRef

go back to reference Goto S, Tamura N, Eto K, Ikeda Y, Handa S. Functional significance of adenosine 5’-diphosphage receptor (P2Y12) in platelet activation initiated by binding of von Willebrand factor to platelet GP Ibalpha induced by conditions of high shear rate. Circulation. 2002;105(21):2531–6.PubMedCrossRef Goto S, Tamura N, Eto K, Ikeda Y, Handa S. Functional significance of adenosine 5’-diphosphage receptor (P2Y12) in platelet activation initiated by binding of von Willebrand factor to platelet GP Ibalpha induced by conditions of high shear rate. Circulation. 2002;105(21):2531–6.PubMedCrossRef

go back to reference Hung DZ, Wu ML, Deng JF, Yang DY, Lin-Shiau. Multiple thrombotic occlusions of vessel after Russell’s viper envenoming. Pharmacol Toxicol. 2002b; 91(3): 106-10 Hung DZ, Wu ML, Deng JF, Yang DY, Lin-Shiau. Multiple thrombotic occlusions of vessel after Russell’s viper envenoming. Pharmacol Toxicol. 2002b; 91(3): 106-10

go back to reference Schrör K. Clinical pharmacology of the adenosine diphosphate (ADP) receptor antagonist, clopidogrel. Vascular Med. 1998;3(3):247–51.CrossRef Schrör K. Clinical pharmacology of the adenosine diphosphate (ADP) receptor antagonist, clopidogrel. Vascular Med. 1998;3(3):247–51.CrossRef

go back to reference Tans G, Rosing J. Snake Venom Activators of Factor X: An overview. Haemostasis. 2001;31(3-6):225–33.PubMed Tans G, Rosing J. Snake Venom Activators of Factor X: An overview. Haemostasis. 2001;31(3-6):225–33.PubMed

go back to reference Yamada D, Sekiy F. Prothrombin and factor X activator activities in the venoms of Viperidae snakes. Toxicon. 1997;35(11):1581–9.PubMedCrossRef Yamada D, Sekiy F. Prothrombin and factor X activator activities in the venoms of Viperidae snakes. Toxicon. 1997;35(11):1581–9.PubMedCrossRef

go back to reference MacFarlane RG. The coagulant action of Russell’s viper venom: the use of antivenom in defining its reaction with a serum factor. Br J Haematol. 1961;7:496–511.PubMedCrossRef MacFarlane RG. The coagulant action of Russell’s viper venom: the use of antivenom in defining its reaction with a serum factor. Br J Haematol. 1961;7:496–511.PubMedCrossRef

go back to reference Furie BC, Furie B. Coagulant protein of Russell’s viper venom. Methods Enzymol. 1976;45:191–205.PubMedCrossRef Furie BC, Furie B. Coagulant protein of Russell’s viper venom. Methods Enzymol. 1976;45:191–205.PubMedCrossRef

go back to reference Takeya H, Nishida S, Miyata T, et al. Coagulation factor X activating enzyme from Russell's viper venom (RVV-X). A novel metalloproteinase with disintegrin (platelet aggregation inhibitor)-like and C-type lectin-like domains. J Biol Chem. 1992;267(20):14109–17.PubMed Takeya H, Nishida S, Miyata T, et al. Coagulation factor X activating enzyme from Russell's viper venom (RVV-X). A novel metalloproteinase with disintegrin (platelet aggregation inhibitor)-like and C-type lectin-like domains. J Biol Chem. 1992;267(20):14109–17.PubMed